Placebo MAD

DRUG2 trials

Sponsors

Galapagos NV, LifeMine Therapeutics

Conditions

HealthyHealthy Volunteers

Phase 1

A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects

CompletedNCT03899909

Galapagos NVHealthy

Start: 2019-03-29End: 2019-06-03Updated: 2019-07-05

A Phase I Study to Evaluate LIFE-001

RecruitingNCT06904807

LifeMine TherapeuticsHealthy Volunteers

Start: 2025-04-07End: 2026-11-13Target: 160Updated: 2026-07-07